AndhraNews.net
Home » Features » Health » Blood test

Blood test


About Blood test

Blood test is considered the most basic test done to diagnose the health status of a patient.

Blood test in News

Curb Energy Consumption
(Family Features) Water heaters are energy intensive appliances. In fact, they are the second largest energy user in the home, and as they age, they become less efficient, requiring even more energy.

Market commentary: Medical technology - Gold rush times in diagnostics
Bellevue Asset Management /Market commentary: Medical technology - Gold rush times in diagnostics. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Online Disruptive Technologies Announces Approval to Perform Diagnostic Clinical Trials on Human Blood
Online Disruptive Technologies, Inc. (OTC PINK: ONDR) (the "Company") is pleased to announce that its majority owned Israeli subsidiary, Savicell Diagnostic Ltd

SomaLogic Announces Agreement to Place SOMAscan(R) Proteomics Assay in FDA's National Center for Toxicological Research
BOULDER, CO--(Marketwired - December 14, 2015) - SomaLogic, Inc., announced today that the U.S. Food and Drug Administration's (FDA) National Center for Toxicological Research (NCTR) has made an agreement with SomaLogic to deploy the SOMAscan proteomics assay in the NCTR's research laboratories in Jefferson, AK

Timothy Henn, Experienced Genomics Diagnostics and Life Sciences Executive, Joins CardioDx as Chief Financial Officer
CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today the appointment of Timothy Henn as Chief Financial Officer of the company.

SomaLogic and Otsuka Pharmaceutical Scientists Publish Study Demonstrating Therapeutic Potential of a Novel SOMAmer Reagent for Rheumatoid Arthritis

SomaLogic Announces College of American Pathologists (CAP) Accreditation of Its CLIA Laboratory
BOULDER, CO--(Marketwired - December 01, 2015) - SomaLogic, Inc. announced today that its SomaLogic Clinical Laboratory (CLIA laboratory) has been registered with the Centers for Medicare and Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments of 1988, and has received accreditation by the College of American Pathologists (CAP).

Iris BioTechnologies Inc. Reports on Legal Proceedings Involving Heller Ehrman LLP
SANTA CLARA, CA--(Marketwired - November 25, 2015) - On November 20, 2015, the Ninth Circuit Court of Appeals affirmed the lower court decision denying Iris's motion to file a malpractice claim against its former legal counsel Heller Ehrman LLP. Heller Ehrman was a reputable, one-hundred-plus-years-old law firm with more than 600 attorneys

Multi-Center, Community-Based Patient Registry Interim Results Presented at the AHA Scientific Sessions Support the Clinical Utility of the Corus(R) CAD Test in the Assessment of Obstructive Coronary Artery Disease
CardioDx, Inc

Joshua Hellmann Foundation and Mead Johnson Nutrition Call on Expecting Parents to Take the VITAL STEP to Have Their Newborn Screened for Inborn Errors of Metabolism
Joshua Hellmann Foundation for Orphan Disease (JHF) and Mead Johnson Nutrition (MJN) today announced the VITAL STEP program, a territory-wide education initiative and free(1) screening support for Inborn Errors of Metabolism (IEM). IEM are rare metabolic diseases that can hamper childhood development and even cause death. In Hong Kong, about one in every 4,000 newborn babies suffers from IEM(2)

Eric Lefkofksy -- Entrepreneur and Wife Liz Donate $1.2 Million to University of Michigan for Medical Research
CHICAGO, IL--(Marketwired - October 16, 2015) - Eric Lefkofsky, CEO and Co-founder of Groupon, and his wife Liz have pledged $1.2 million to the University of Michigan Health System to further the development of cancer and heart disease research

CardioDx Announces Positive Data From a Large Primary Care Registry on the Impact of the Corus CAD Test in the Assessment of Obstructive Coronary Artery Disease in Women
CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a subgroup analysis of the primary efficacy endpoint of the community-based patient registry, the PRESET Registry

Winterize Your Body With Phase 2 White Kidney Bean Extract
Call it human nature, but starting in fall and throughout winter, most people can't resist indulging in carb-loaded foods. While it is unknown exactly why this urge occurs, it may be a trait leftover from our pre-historic ancestors to store extra energy as a survival, hibernation technique for harsh winters, or simply spawned by a childhood memory of warm cookies and coco during the holidays

SomaLogic Launches New, Larger Commercial Version of SOMAscan(TM) Proteomic Assay
BOULDER, CO--(Marketwired - September 23, 2015) - SomaLogic announced today that the latest version of its proprietary SOMAscan proteomics assay, which now measures 1,310 protein analytes, is commercially available to the life science research community. Called "SOMAscan Assay 1.3k," this new version is replacing the current 1,129-measurement version, but without an increase in price.

CardioDx Expands Patient Access to the Corus(R) CAD Test Through National Agreement With Quest Diagnostics
CardioDx, Inc

SomaLogic and Otsuka Pharmaceutical Extend Research Collaboration for Therapeutic SOMAmer(R) Development
BOULDER, CO--(Marketwired - August 10, 2015) - SomaLogic, Inc., announced today that Otsuka Pharmaceutical Co., Ltd. has extended its initial collaboration agreement with SomaLogic to continue the development of several SOMAmer® therapeutics. Specific projects and financial terms in the extended agreement were not disclosed.

SomaLogic Announces Commercial Availability of Individual SOMAmer(R) Reagents for Life Science and Biopharma Researchers
BOULDER CO--(Marketwired - July 08, 2015) - SomaLogic, Inc., announced today that it is making its proprietary SOMAmer®(Slow Off-rate Modified Aptamers) reagents commercially available as individual molecules to the life science and biopharma scientific communities for their specific protein-affinity research needs

Widespread Overtreatment of Benign Lung Nodules Seen in Landmark Chart Review Study
Indi (Integrated Diagnostics®) today announced CHEST has published a landmark chart review study, suggesting widespread overtreatment of benign lung nodules in the indeterminate range of 8 to 20 mm. The retrospective study of 377 patients sought to describe how pulmonologists typically manage these patients in their standard practice and to estimate the prevalence of cancer

Weill Cornell Medical College in Qatar and SomaLogic Announce Agreement to Deploy the Automated Version of SOMAscan Assay
DOHA, QATAR and BOULDER, CO--(Marketwired - June 15, 2015) - Weill Cornell Medical College in Qatar (WCMC-Q) and SomaLogic announced today that the automated version of the SOMAscan assay, which has been previously available only at SomaLogic's headquarters in Boulder, CO, will be installed at the WCMC-Q Education City campus in Doha, Qatar

Novartis drug Arzerra® improved median progression-free survival by 54% in patients with relapsed chronic lymphocytic leukemia
Novartis International AG /Novartis drug Arzerra® improved median progression-free survival by 54% in patients with relapsed chronic lymphocytic leukemia . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

CardioDx Raises $35 Million in Equity Financing
CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the close of $35 million in total equity financing. Alberta Investment Management Corporation (AIMCo) participated in this round together with the company's existing investors.

One Woman's Story: Living and Helping Others With Inherited Lung Disorder
(Family Features) Wheezing, shortness of breath and chronic bronchitis are often associated with asthma or chronic obstructive pulmonary disease (COPD). However, they are also symptoms of a serious genetic form of emphysema called Alpha-1 Antitrypsin Deficiency, also known as Alpha-1.

DNA Sequencing Breakthrough -- Ex-Groupon CEO Joins Prenetics, Launches Non-Invasive Prenatal Test in Hong Kong
Prenetics™, a DNA biotechnology company, announces Danny Yeung has joined the company as its CEO and investor, as well as having led a $2.65M USD strategic seed funding round of high profile international investors into the company. Danny most previously was CEO of Groupon East Asia after having his start-up uBuyiBuy acquired by Internet Giant Groupon in 2010

New Hair Loss Treatment Offered by Orange County Plastic Surgeon
Platelet Rich Plasma (PRP) therapy, a skin rejuvenation technique used for a treatment called the Vampire Facial, has recently been gaining popularity as a natural method of reducing the appearance of fine lines and wrinkles. However, this same technique can also be used for hair restoration. Dr

Indi(R) Secures Contracts for Xpresys(R) Lung With Multiplan and Five Other PPOs; Blood Test for Pulmonary Nodules Now Available to 200 Million Covered Lives
Indi® (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced that the company has secured contractual agreements with MultiPlan and five other PPOs (preferred provider organizations) for Xpresys® Lung, the first non-invasive molecular blood test for the assessment of pulmonary nodules

CardioDx Announces Results of Study Demonstrating the Benefits of the Corus CAD Gene Expression Test Use in an African American Patient Population
CardioDx, Inc

Low Testosterone: FDA Panel Calls for Reduction in Low T Prescriptions
According to a recent U.S. Food and Drug Administration (FDA) advisory panel vote, drugs for low testosterone (Low T) should only be prescribed to men with genetic disorders or tumors that cause reduced testosterone levels

Live Well Clinic Is Now Offering an Innovative Blood Test to Evaluate Heart Artery Blockages in Patients
Coronary artery disease (CAD) is one of the most common and most serious health conditions in the United States. In fact, one in six deaths among Americans is caused by CAD.(1) CAD is characterized by the buildup of plaque in arteries, which may cause a narrowing, or blockage, decreasing the amount of blood reaching the heart muscle

Blood Test for VEGF-A, TGF-B1 Prior to Treatment Could Help Determine Tailored Treatment Options for Esophageal Cancer Patients
SAN FRANCISCO, CA--(Marketwired - September 14, 2014) - A blood test may be beneficial in indicating neoadjuvant treatment regimens for patients with esophageal squamous cell carcinoma (ESCC), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th Annual Meeting

New Surgeon Specializing in Cornea, LASIK, Cataract and Glaucoma Joins Utah Eye Care Practice
The Eye Institute of Utah recently announced the addition of ophthalmologist Zachary J. Zavodni, MD to its team. Dr. Zavodni specializes in cornea, refractive cataract and glaucoma surgery. He performs advanced corneal transplant surgeries including PKP, DSEK, and Intacs®, along with corneal crosslinking for the treatment of keratoconus

ALR Technologies Begins Enrolling Patients in Kansas City
ALR Technologies Inc. (OTCQB: ALRT), the chronic care medical device company, is pleased to announce the first large-scale commercial deployment of Health-e-Connect, the Company's robust remote disease management platform

CORRECTION - www.roboticoncology.com
In the news release "Prostate Cancer Know-How," issued yesterday by www.roboticoncology.com, we are advised by the client that text was included in the boilerplate paragraph that was not meant to be issued. Complete corrected text follows.

Prostate Cancer Know-How
As predicted earlier this year, prostate cancer is continuing its strong presence among U.S. men. While the American Cancer Society predicts that more than 230,000 men will be diagnosed with prostate cancer this year, outcomes remain positive. David B

The Kansas City Metropolitan Physician Association and ALR Technologies Announce Diabetes Management Partnership
ALR Technologies Inc. (OTCQB: ALRT), the chronic care medical device company, announced a commercial partnership with the Kansas City Metropolitan Physician Association (KCMPA), one of the nation's premier Accountable Care Organizations (ACO)(1)

CardioDx Announces Aetna and Coventry Health Coverage for Corus(R) CAD Gene Expression Test
CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, confirmed today that Aetna has established a clinical policy for the company's Corus® CAD gene expression test. With this decision, the Corus CAD gene expression test is eligible for coverage among Aetna and Coventry Health members

Atomo Diagnostics' AtomoRapid(TM) HIV Device, Designed and Developed by ide, Named Best-in-Show Winner at 2014 Medical Design Excellence Awards
ide, a new product development group, announced today that the AtomoRapid™ HIV device designed and developed by ide under contract with Atomo Diagnostics, a medical technology company, was selected as the "Best-in-Show" winner at the 2014 Medical Design Excellence Award (MDEA). The device also won the Gold award for the In Vitro Diagnostic Products and Systems category

Man's Best Friend Sniffs Out Prostate Cancer
Once again, man's best friend proves a reliable companion. Research presented at the 2014 American Urological Association annual meeting showed that highly trained cancer detection dogs were able to identify prostate cancer in urine samples with 98 percent accuracy

Prostate Cancer News: On the Scent of Something Big
The nose knows, in this case, whether or not you have prostate cancer. A new study reveals the electronic nose, or eNose, to be an effective tool for distinguishing between prostate cancer and benign prostatic hyperplasia (BPH) in urine samples

New Study Results Further Reinforce That the Corus(R) CAD Test Helps Primary Care Clinicians Make Effective Referral Decisions for Patients With Suspected Obstructive Coronary Artery Disease
CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of the REGISTRY I study, which examined the assessment of non-acute chest pain and related symptoms that may be suggestive of obstructive coronary artery disease (CAD) in the primary care setting with the Corus® CAD blood-based gene expression test

EDP Biotech Announces CE Mark Approval for ColoMarker an in Vitro Diagnostic Aid in Early Detection of Colon Cancer and Plans for Commercialization in Europe
EDP Biotech Corporation, (“EDP,” or the “Company”), a global in vitro diagnostic innovator of life-saving, easy-to-use cancer diagnostic tests using ELISA technology, has announced CE Mark approval for ColoMarker® , an aid in early detection of Colon Cancer

Chicago Awareness Organization First Not-for-Profit to Sponsor Dog Training to Detect Ovarian Cancer Odorants
The Ovarian Cancer Symptom Awareness Organization (OCSA) continues to unleash innovative ways to educate women and their families about the silent symptoms of ovarian cancer and the importance of early detection

Hidden Heart Risk Revealed: New Non-Profit Empowers Approximately 30% of Americans at Risk for Cardiovascular Disease to Be Advocates for Their Heart Health
SAN FRANCISCO, CA--(Marketwired - November 16, 2013) - Cardiovascular disease is the #1 killer of Americans, yet 50% of hospital admissions for coronary artery disease have normal LDL-cholesterol(i). The Lipoprotein(a) Foundation is revealing this hidden risk for patients.

EasyMed Implements Its Easy SmartCare Technology in the Cardiology Department of University Hospital Geneva (HUG)
EasyMed Services Inc. (www.EasyMedMobile.com) (CNSX: EZM)(OTCBB: EMYSF)(MUN: EY6) today announced that the cardiology department of HUG has begun using its Easy SmartCare technology.

Genomind Announces Licensing Agreement With Emory University to Commercialize Novel Alzheimer's Risk Biomarkers
CHALFONT, PA--(Marketwired - November 04, 2013) - Genomind, a personalized medicine company, today announced a licensing agreement with Emory University (www.emory.edu) to partner in the commercialization of the first blood-based screening test for Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Indi(R) Announces Availability of Xpresys(TM) Lung Blood Test With Potential to Help Physicians Identify More Lung Nodules as Likely Benign and More Patients as Possible Candidates for Active Surveillance Instead of Invasive Procedures

Study Suggests Indi Blood Test Can Differentiate Between Benign Lung Nodules and Early Stage Lung Cancer
Indi (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced the results of a major study which suggests that quantifying a combination of blood proteins can distinguish between benign lung nodules and early-stage lung cancer with high probability

The PROOF Centre of Excellence Partners With HTG Molecular Diagnostics to Begin Clinical Validation of Heart Transplant Rejection Blood Test
The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and HTG Molecular Diagnostics are collaborating to begin clinical validation of a biomarker blood test that will provide early indication of organ rejection in heart transplant patients

Heart Disease Trial Results Show Positive Patient Impact
A non-invasive blood test is now available that may help physicians exclude coronary artery disease risk in certain patients. Results from a clinical trial investigating an innovative assessment test provided information that can help physicians decide which patients do not need additional diagnostic testing for obstructive coronary artery disease (CAD)

Company Reports on Latest Financing, Human Resource and Business Development Activities
EasyMed Services, Inc. (CNSX: EZM)(OTCBB: EMYSF)(MUN: EY6) (the "Company" or "EasyMed") is a global medical information technology company delivering an end-to-end patient care solution through mobile phone, PDA and server technologies.

LaPorte Animal Clinic Veterinarian Earns Accreditation
LaPorte Animal Clinic announces that its veterinarian, Dr. Marta Dean, has recently updated her accreditation status with the USDA for animal health certificates, in accordance with the new USDA regulations. This allows her to issue health certificates for large or small animals that are taking trips, including animals going to other countries. (Dr

ALRT's Internet-Based Glucose Monitoring Platform Compares Favorably With Medtronic's Continuous Glucose Monitoring System: Clinical Trial Results Reported at ADA's 73rd Scientific Sessions

La Jolla Pharmaceutical Company Releases Data Indicating GCS-100 May Improve Renal Function
La Jolla Pharmaceutical Company (OTCBB: LJPC) ("La Jolla" and "Company"), a leader in the development of therapeutics targeting galectin proteins, released data today detailing the ability of lead product candidate GCS-100 to improve renal function

Atossa Genetics to Present at the Sidoti Semi-Annual Microcap Conference
Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced that Dr. Steven Quay, chairman, CEO and president, will be presenting at the Sidoti Semi-Annual Microcap Conference on Friday, June 7, 2013, at 2:00 p.m. Eastern Time, at the Grand Hyatt Hotel in New York City

Atossa Genetics Reports First Quarter 2013 Results and Operating Highlights
Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced its first quarter 2013 financial results and corporate developments.

Atossa Genetics to Present at the Sachs Associates Cancer Bio Partnering Forum and Participate on the Cancer Tech Panel
Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven Quay, Chairman, CEO & President, will speak and participate on the Diagnostics panel at the Sachs Associates Cancer Bio Partnering Forum on Wednesday, May 22, 2013, at the Westin Copley Place in Boston, Massachusetts. Dr. Quay's corporate presentation will take place from 11:00 a.m

Atossa Genetics Signs Distribution Agreement With Millennium HealthCare
Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has signed an agreement with Millennium HealthCare Inc. (PINKSHEETS: MHCC) for the distribution by Millennium Medical Devices of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits

Atossa Genetics to Present at FSX San Francisco Investor Conference
Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, CFO and General Counsel, will present the Company's business model, products and services, and investment thesis at the FSX San Francisco Conference at the Ritz Carlton Hotel in San Francisco on Thursday, April 25, 2013, beginning at 2:40 pm Pacific Time.

Atossa Genetics to Provide ForeCYTE Breast Health Test to Two Leading Breast Centers in Texas
Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will soon begin providing its patented ForeCYTE Breast Health Test for early detection of precursors to breast cancer at two breast centers in Texas: Aurora Breast Center in San Antonio and The Breast Center at Wellness Lubbock in Lubbock

Atossa Genetics Reports 2012 Results and Operating Highlights
Atossa Genetics, Inc

Online Consultation Portal DoctorSpring.com Adds 3 Super-specialties, Now has 600 Doctors in over 40 specialties
E-commerce is springing up like a rage; we can now even pay Government corporation bills online. But when it comes to my health, we can’t quickly consult a Doctor online to check about my symptoms, get an opinion about a blood test, get a second opinion about a complex procedure like back surgery, or get a personalized opinion of a Dermatologist by uploading a picture

Atossa Genetics Announces Third Quarter 2012 Financial Results
Atossa Genetics, Inc. (NASDAQ: ATOS) today announced financial results for the third quarter of 2012, ended September 30, 2012.

Atossa Genetics, Inc. to Present at the 5th Annual LD Micro Conference
Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Dr. Steven C. Quay, M.D., Ph.D., FCAP, chairman, CEO and president of Atossa Genetics, Inc., will present at the 5th Annual LD Micro Conference on Wednesday, December 5, 2012, at 10:00 AM Pacific Time, at the Luxe Sunset Bel Air Hotel in Los Angeles, California.

Blood Test With Potential to Detect Stage One Cancer: Soricimed Biopharma Inc. Announces Initiation of Cancer Diagnostic Study
Soricimed Biopharma Inc., a private clinical stage company developing novel cancer therapeutics and diagnostics, announced that a pre-regulatory study of their blood test for early detection of cancer has commenced.

Breakthrough Cancer Detection Test Could Soon Be Available in Canada
(NASDAQ: PANG)(OTCBB: PANG) - Canadian healthcare providers could soon have access to a powerful new laboratory test for the detection and ongoing management of four common types of cancer, including those from lung, prostate, breast and colon. This test could be used by physicians in the workup of a suspected cancer case; and may also be employed to monitor remission and recurrence.

With Millions Projected to Hit the Road This Labor Day Weekend, LA Lawyer Expects to Give DUI Advice 24/7
The American Automobile Association (AAA) of Southern California projects that 1.85 million Californians will hit the road this holiday weekend. More drivers on the road correlate to more law enforcement on Los Angeles highways, more DUI arrests, and more drivers needing legal advice from a DUI attorney.

Soricimed Biopharma Inc. Commences the Design and Development of Biologic Drug Conjugates
Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, is collaborating with Mount Allison University to design and develop new biologic drug conjugates for oncology based on the company's proprietary drug delivery system

Houston's Bay Area Gastroenterology Specialists Discuss Prevalence of Hepatitis C in Baby Boomer Population and Treatments Saving Lives
The Houston gastroenterologists at Bay Area Gastroenterology alert patients to the prevalence of Hepatitis C among the "baby boomer" population and the simple blood test that can identify this silent disease.

Boston Therapeutics Completes Enrollment in Phase ll Clinical Trial to Evaluate PAZ320 in Patients With Type 2 Diabetes
Boston Therapeutics, Inc

Chembio Diagnostics Announces Positive Data From Independent Study of Rapid, Point-of-Care Hepatitis C Test Published in the Journal of Clinical Virology
Chembio Diagnostics, Inc

Partnership With LabCorp Makes WellnessFX Available at 300+ Locations Throughout California, Oregon and Washington
WellnessFX, a simple and accessible online service that allows people to understand and improve their health, has partnered with LabCorp, a leading provider of medical lab tests and services, expanding WellnessFX service to more than 300 LabCorp locations across California, Oregon, and Washington

Soricimed Biopharma Inc. Attending 2012 BIO International
Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, will be exhibiting with the Atlantic Canada Bio-industries Alliance (booth #735) at 2012 BIO International Convention, taking place at the Boston Convention & Exhibition Centers, June 18-21.

Health officials advise baby boomers to get tested for hepatitis C
Hepatitis C virus takes years to show symptoms

Exercise and dieting cuts heart disease risk in obese older adults
Adding exercise to a weight loss program like dieting has more benefit for obese older adults who want to reduce their chances of developing the metabolic syndrome, scientists say.

Treatment for vitamin D deficiency may benefit depressed patients
Screening at-risk depressed patients for vitamin D deficiency and treating it appropriately may be an easy and cost-effective adjunct to mainstream therapies for depression, an Indian origin researcher has said.

Doc offers health advice to dads on Father's day
Doctors say men, on average, die younger than women, and have higher mortality rates from heart disease, cancer, stroke and AIDS.

Natural antioxidant can help protect against cardiovascular disease
Scientists have discovered an enzyme that, when found at high levels and alongside low levels of HDL (good cholesterol), can dramatically reduce the risk of cardiovascular disease.

IOC to use testosterone levels to test if athletes can compete as women
The International Olympic Committee has adopted new regulations for determining whether an athlete should or should not be allowed to compete as a woman.

Khloe Kardashian opts for fertility treatments to have baby with hubby Lamar Odom
Khloe Kardashian, who has always been vocal about her desire to get pregnant, is reportedly looking into fertility treatments.

Blood test for pregnant women may predict risk of having dangerously small babies
Researchers have found a protein in the blood of pregnant women that can predict if they are likely to have a fetus that doesn't grow properly, and thus has a high risk of stillbirth and long-term health complications.

Common BP drug linked to severe gastrointestinal problems
Researchers have discovered an association between a commonly prescribed blood pressure drug, Olmesartan, and severe gastrointestinal issues such as nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities-symptoms common among those who have celiac disease.

Frost & Sullivan Commends Biodesix for Raising the Bar in Personalized Medicine Diagnostics With the VeriStrat(R) Test
Based on its recent analysis of the cancer diagnostics market, Frost & Sullivan recognizes Biodesix with the 2011 North America Frost & Sullivan Award for Product Differentiation Excellence. Biodesix's significant investment in validation, clinical research and basic R&D has made it a leading diagnostic service provider in an industry that often lacks clinically validated biomarkers

Simple blood test detects Parkinson's disease long before symptoms
Scientists have developed a simple blood test to detect Parkinson's disease at its earliest stages.

Soon, simple blood test to identify smokers at high risk for heart disease
A simple blood test could someday be used to measure a smoker's lung toxicity and danger of heart disease, a new study led by an Indian-origin researcher

Now, cheap blood test to predict breast cancer relapse risk
A simple and cheap blood test that can predict which women with the most common type of breast cancer are at risk of the disease returning.

Biomarker gene target identified to track Huntington's disease
Scientists have identified a biomarker gene that could be used to follow the activity of Huntington's disease as well as the response patients might have to neuroprotective treatments.

Gene behind chronic blood cancer identified
Scientists have discovered gene mutations that could enable diagnosis of chronic blood cancer using only a blood test, making invasive and painful bone marrow biopsy a thing of the past.

Yellow patches around eyelids indicate risk of heart problems
A new study has found that raised yellow patches of skin (xanthelasmata) around the upper or lower eyelids are markers of an individual's increased risk of having a heart attack or suffering from heart disease.

Proteins in blood associated with early lung cancer development found
A team of scientists has discovered proteins in the blood that are associated with early lung cancer development in mice and humans.

Soon, diagnose heart attacks using new blood test
A team at the Loyola University Chicago Stritch School of Medicine, led by the Indian-origin scientist, has suggested that a possible new blood test based on the presence of a protein, released to the blood following a heart attack, could help diagnose an attack.

Gujarat Health Minister denies HIV infection during treatment
Gujarat Health Minister Jay Narayan Vyas on Sunday contradicted reports that at least 23 children, suffering from blood disease, were infected with HIV during blood transfusion in a government hospital in Junagadh town.

Comment on this story

Share